Replies to post #299115 on Anavex Life Sciences Corp (AVXL)

[McMagyar]

I think the Aussies are in the same position as the US but different..

The same position in that dementia is destroying their private GDP productivity and inflating their Govt budget ..

Different position in that US Govt has a great asset base and May print more fake inflationary money than Aussies May..

So same problem but different time frame foe solution.. Aussies will be destroyed long before USA.. Also.. if Aussies are smart.. they will cut a deal with Anavex so that Australia gets a piece of the Anavex pie.. May e some of those preferred shares for their healthcare system.. or a great low price or Anavex agrees to manufacture Blarcamesine in Australia..but cut a deal while Anavex still needs you..

[Jonjones325]

Good thought. There was definitely a reason why Missling did it that way. Not expanding recruitment sites internationally sooner definitely slowed things down. Hopefully when we look back we will understand why.

Maybe that was when we “officially”transitioned to a phase 3.

[Investor2014]

Don't forget it is a blinded trial and that Missling is reluctant to spend an interim look risking problems with the statistical power and chances of approval at the end of the pivotal trial. I agree with Missling.

OLE data could be an option, but not too many patients have completed 48 weeks of OLE at this point in time.

Think we need to be prepared to wait for 2nd half of 2022 for the AD readout.